This study identified that bronchial epithelial cells from asthma patients have elevated uPAR levels, that may in part contribute to a defective barrier and blocking specific uPAR functions can enhance this barrier, providing a therapeutic opportunity. The gene discussed is PLAUR; the disease is asthma.